Miscarriage Prevention: What Science Can Do And Why It’s Not Your Fault
Miscarriage. You can find lots of definitions, from the rather cold “spontaneous or unplanned expulsion of a fetus from the womb before it is able to survive independently,” to the softer “sudden loss of a pregnancy before the 20th week.” Either way, it sucks. If you have had one, I’m sorry. So why do women …
Lara Joins Springboard Women’s Health Accelerator 2025 Cohort
Our co-founder Lara Zibners MD MMEd MBA has been selected to join the Springboard Enterprises 2025 Women’s Health Cohort! Lara joins a cohort featuring 12 companies that are driving innovation in areas that differently, predominantly, or solely impact women. Over the next 3 months, the selected entrepreneurs will participate in an intensive accelerator program, working …
LSI Emerging Medtech Conference Day 1
The first day of the LSI Emerging Medtech conference in Dana Point, CA was superb – capped off by our well-received presentation on our Callavid® vaginal drug delivery platform. 💪 No doubt buoyed by the momentum surrounding opportunities in women’s health – there was a real buzz leading up to and following our presentation. We’re …
Attending LSI USA 25
We’re delighted to be heading to Dana Point, CA during the LSI conference! From March 17th-21st, we’ll be ready to connect, collaborate, and showcase our Callavid® vaginal drug delivery innovation at one of medtech’s premier partnering events. This is an exciting opportunity to discuss new trends, potential collaborations, and meet with valued partners and industry …
Lara discussing the role of Innovation in Closing the Gender Healthcare Gap
Still buzzing from an exceptional Future of Healthtech Hub event last night hosted by THENA Capital at M&G Investments. A memorable night between the intimate crowd and superb panel of experts including Professor Dame Lesley Regan (the UK’s Women’s Health Ambassador for England), Alliott Cole, MD of Octopus Ventures (member of the Invest in Women …
EMBAs from MIT Sloan boosting CLCC’s US strategy
We’re delighted to welcome Jaren, Humaira and TJ to our offices – three dynamic Executive MBAs from MIT Sloan School of Management who are working closely with Lara, myself and the rest of our Calla Lily Clinical Care leadership team over the next 4 months. As part of MIT Sloan’s Global Organizations action learning lab …
Panel at M&G Investments: The Role of Innovation in Closing the Gender Healthcare Gap
We’re looking forward to hearing perspectives from an esteemed panel of experts (including our co-founder Lara Zibners) on the role of innovation in Closing the Gender Healthcare Gap, hosted by THENA Capital in collaboration with M&G Investments. Lara will be sharing the stage with Professor Dame Lesley Regan – Women’s Health Ambassador for England and …
Beyond Infertility: Progesterone for Menopause, PCOS, and Endometriosis
When you hear the word “progesterone”, the hormone’s role in fertility treatments may be the first thing that comes to mind. After all, it’s “pro” “gest.” Get it? However, progesterone is not just for women trying to conceive—it also has a critical role in the management of other conditions that affect women throughout their lives. …
R&D team excellence
A shout-out to our incredible Calla Lily Clinical Care Team. With some key deadlines approaching, our R&D team has been working with relentless dedication, precision, and an unwavering commitment to excellence.💥 This is where the real ✨magic happens at our firm – brilliant minds, working hard, driven by purpose, coming together to push the boundaries …
200 Trailblazing Leaders in Women’s Health & FemTech
Our co-founders Lara and Thang have been named in the annual ‘200 Trailblazing Leaders in Women’s Health and FemTech’ for the second year running. It’s a real who’s who of the influential leaders working to improve the access and quality of healthcare for women worldwide. We’re delighted at the recognition for Lara & Thang and …